Let It Burn So You Can Rise

Courtney Stanley made a bold shift in her career at the end of 2019 and early 2020. She decided to pursue the path of entrepreneurship. She is a keynote speaker, event emcee, podcaster, and coach. Her humility is personable, and her approach is empowering. “It’s important to remember that you’re really only seeing the tip of the iceberg when you see people on stage, hear them on a podcast. You’ve missed the struggle to get there,” said Stanley.

Stanley didn’t experience her success without pulling herself out of a few ruts and difficult days. “A few things really helped me, understanding what the purpose of my work was. If all the shiny things were stripped away, what actually motivates me to do this work? And when I thought about it, it really boiled down to my desire to spark meaningful conversations. I couldn’t put a dollar amount on that,” said Stanley. For any event marketers, coordinators, or directors who are struggling or feeling burnout, she recommends “get back to your mission, dig deeper to what you love about the job specifically.”

Mental health is a significant component of getting through those difficult times. “You can’t pour from an empty cup,” said Holly Criswell, episode host. “I had to recognize that if I wasn’t in a great state mentally and emotionally, I was not going to be able to pursue that mission,” said Stanley. She shifted her to-do list to joy-focused things and found that joy brought momentum. It included things like interacting with people who energized her and her mental health, like journaling and working out.

“It’s difficult to find work-life balance if you aren’t in the right environment,” said Stanley. Some environments are not supportive of striking that balance. If that’s the situation, Stanley recommends being open to alternative settings and points out that the current job market favors candidates.

Later in the episode, Criswell and Stanley discuss techniques to shift away from imposter syndrome. Stanley offers straightforward practices to combat imposter syndrome.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More